In a small, short duration trial (12 weeks), a new medication called DR10624 reduced triglyceride levels in most patients ...
News-Medical.Net on MSN
Novel triple receptor agonist shows potent efficacy in lowering high triglycerides
In a small, short duration trial (12 weeks), a new medication called DR10624 reduced triglyceride levels in most patients with severe hypertriglyceridemia by more than 60%, according to a preliminary ...
The rapid development and integration of artificial intelligence (AI), including predictive, generative, and emerging agentic ...
Discover how biology, hormones, and social expectations combine to hide ADHD in girls, revealing the science behind why their ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果